ICE
74
4
PPL
80
5
KMX
54
2
RSG
73
3
PFG
52
7
D
43
3
HD
41
3
VLO
45
3
CMCSA
48
2
GME
52
5
ZBH
65
3
BXP
38
4
HST
34
2
EQT
59
5
MCD
59
4
WEC
82
4
ES
43
4
PNW
73
2
STT
56
3
GPC
53
2
ICE
74
4
PPL
80
5
KMX
54
2
RSG
73
3
PFG
52
7
D
43
3
HD
41
3
VLO
45
3
CMCSA
48
2
GME
52
5
ZBH
65
3
BXP
38
4
HST
34
2
EQT
59
5
MCD
59
4
WEC
82
4
ES
43
4
PNW
73
2
STT
56
3
GPC
53
2
Financhill
Back

Vertex Pharmaceuticals 10K Form

Buy
61

VRTX
Vertex Pharmaceuticals

Last Price:
$504.63
Seasonality Move:
11.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-07 10Q VRTX/Vertex Pharmaceuticals Quarterly
2024-02-15 10K VRTX/Vertex Pharmaceuticals Annual
2023-11-07 10Q VRTX/Vertex Pharmaceuticals Quarterly
2023-08-02 10Q VRTX/Vertex Pharmaceuticals Quarterly
2023-05-02 10Q VRTX/Vertex Pharmaceuticals Quarterly
2023-02-10 10K VRTX/Vertex Pharmaceuticals Annual

Receive VRTX News And Ratings

See the #1 stock for the next 7 days that we like better than VRTX

VRTX Financial Statistics

Sales & Book Value

Annual Sales: $11B
Cash Flow: $492M
Price / Cash Flow: 30.13
Annual Sales: $63.87
Price / Book: 7.9

Profitability

EPS (TTM): -2.20000
Net Income (TTM): $-535.6M
Gross Margin: $9.5B
Return on Equity: -3.23%
Return on Assets: -2.4%

Vertex Pharmaceuticals Earnings Forecast

Key Vertex Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 34 years for VRTX is 86.11%.
  • The Selling, General & Administrative Expenses for VRTX have been equal to 13.29% of Gross Profit Margin.
  • The Research & Development expenses have been 32.94% of Revenue.
  • The Net Earning history of VRTX is -4.86% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 14 years.

Vertex Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: VRTX
CUSIP: 92532F
Website: vrtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.69
Quick Ratio: 2.17

Price-to-Earnings

Trailing P/E Ratio: 33.84
Forward P/E Ratio: 24.86

VRTX Technical Analysis vs Fundamental Analysis

Buy
61
Vertex Pharmaceuticals (VRTX) is a Buy

Is Vertex Pharmaceuticals a Buy or a Sell?